Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion type Assertion NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_head.
- NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion description "[Additionally, a higher expression of IL-1 beta in serum (p=0.004) and ascites (p=0.05) reduced significantly the progression-free survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_provenance.
- NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion evidence source_evidence_literature NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_provenance.
- NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion SIO_000772 18329282 NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_provenance.
- NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion wasDerivedFrom befree-20150227 NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_provenance.
- NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_assertion wasGeneratedBy ECO_0000203 NP490630.RAhlmkJ0BMJbTzSfY4wMd84J_zgMyN11BmoVlYR3Zdytg130_provenance.